Clinical Use of PTH(1-84) Clinical Trial
Official title:
Adherence to PTH(1-84) Treatment in Europe. A Non-interventional Cohort Study Collecting Safety Information and Examining Reasons and Predictors for Adherence to PTH(1-84) Treatment in Usual Clinical Settings
The primary objective is:
1) to describe adherence (and the main factors influencing adherence) to PTH(1-84) treatment
when prescribed in a normal clinical setting.
The secondary objectives are:
1. to describe the demographics and clinical characteristics of the patients that in a
normal clinical setting are started on a treatment regimen with PTH(1-84)
2. to describe (using available data) the long term treatment effectiveness during the 24
months following initiation of PTH(1-84) treatment in a normal clinical setting
3. to monitor safety for 24 months following initiation of PTH(1-84) treatment in a
patient in a normal clinical setting.
n/a
Observational Model: Case-Only, Time Perspective: Prospective